Texas Based Drug Rehab Summer Sky is changing the face of addiction treatment. They are on course to launch some of the newest evidence based addiction practices as well as cutting edge recovery support systems in 2011. Traditional Drug Rehabs in the last five years have fallen behind the curve, when it comes to advancement of addiction treatment practices. Summer Sky who has been known to introduce new and innovative addiction practices is again making progress in the area of evidence based treatment practices. In 2009 Summer Sky begin the process of building a treatment team that is focused on quality of care and results. They introduced the first Texas 30 day model of treatment to incorporate Equine Therapy, Music Therapy, Art Therapy, Aquatic Therapy. This type of addiction expansion was unheard of for a 30 day treatment program. It was usually the practice of 90 day or long- term drug rehabs that offered this type of services. It did not take long for other Texas Drug Rehabs to begin the process of setting up programs that implemented this type of therapy practices. In 2010 Summer Sky once again pushed the status quo and implemented the first Recovery Team into and addiction treatment program in Texas.
This has allowed the clinical team to focus on solid clinical services and allow the recovery team to work with the clients on individual recovery, just like it is going to be when they get out of treatment. The lines have become clear for the clients on what the 12-steps are all about and how they fit into their life.
The Recovery Team and Clinical Team collaborate on many aspects of and individuals recovery and treatment. Also the facility implemented Massage therapy and Yoga to the programs. This is usually reserved for luxury facilities.
If you are looking for a rehab center that is making a difference in the Addiction Field Summer Sky is to place to go for great treatment.
The addiction treatment community has wrestled for years fighting addictions and pain. Programs have developed different approaches to treating those with chronic pain issues. It is a difficult and a delicate issue that concerns many in the medical and addiction treatment industry. How to properly detoxify a patient and treat the underline pain that the individual is suffering from can be very tricky. The patient will present for drug treatment with the desire to be removed from pain medications, however the fear from the patient of the pain that will present as soon as medications are removed from the body becomes a barrier for the individual seeking treatment. It is a double edge sword and if not properly done, can create unnecessary pain for the patient.
A powerful new painkiller, which was developed on the basis of the research conducted at Stony Brook University and with no apparent side effects or addictive qualities, may now be only a year or two from the consumer market.
"This offers a major paradigm shift in the control of pain," declares Dr. Simon Halegoua, Professor of Neurobiology & Behavior at Stony Brook who in the 1990s, teamed up with fellow Stony Brook professors Dr. Gail Mandel and Dr. Paul Brehm to identify a novel sodium ion channel involved in the transmission of pain. They predicted that a drug aimed at blocking this channel, PN1/Nav 1.7, would control pain. PN1 (Peripheral Neuron 1), is uniquely expressed in peripheral nerves such as those involved in pain transduction.
When a patient is given an opiate like morphine, pain signals are still transmitted from sensory nerves to the central nervous system. Morphine action throughout the brain reduces and alters pain perception, but it also impairs judgment and results in drug dependence," explains Halegoua, also director of the Center for Nervous System Disorders at Stony Brook University. "With drugs targeting the PN1/Nav1.7 sodium ion channel, the pain signals would not be transmitted, even by the sensory nerves. And since the central nervous system is taken out of the equation, there would be no side effects and no addictive qualities."
The potential for such drugs is enormous -- the reduction or elimination of pain for patients with cancer, arthritis, migraine headaches, muscle pain, pain from burns, and pain from other debilitating diseases.
He notes that drugs in both oral and topical ointment forms, based on the research he conducted in a basement laboratory at Stony Brook with Mandel, a molecular biologist, and Brehm, an electro physiologist, are currently in Phase II clinical trials in England and Canada.
The Research Foundation of the State University of New York is the holder of the various patents originating from the work of the Stony Brook researchers. Icagen Inc., now in partnership with Pfizer, holds the exclusive license to these patents and has announced their own drug has now entered Phase I clinical trials in the U.S.
Story Source:
The above story is reprinted (with editorial adaptations by Sober Sky) from materials provided by Stony Brook University.
FULTON, MISS. - When Neil Brown got high on bath salts, he took his skinning knife and slit his face and stomach repeatedly. Brown survived, but authorities say others haven't been so lucky after snorting, injecting or smoking powders with such innocuous-sounding names as Ivory Snow, Red Dove and Vanilla Sky.
Law enforcement agents and poison control centers say the bath salts, with their complex chemical names, are an emerging menace in several U.S. states where authorities talk of banning their sale. Some say their effects can be as powerful as those of methamphetamine.
From the Deep South to California, emergency calls are being reported over exposure to the stimulants the powders often contain: mephedrone and methylenedioxypyrovalerone, also known as MDPV.
Sold under such names as Ivory Wave, Bliss, White Lightning and Hurricane Charlie, the chemicals can cause hallucinations, paranoia, a rapid heart rate and suicidal thoughts, authorities say. In addition to bath salts, the chemicals can be found in plant foods that are sold legally at convenience stores and on the Internet. However, they aren't necessarily being used for the purposes on the label.
Mississippi lawmakers this week began considering a proposal to ban the sale of the powders, and a similar measure is being sought in Kentucky. In Louisiana, the bath salts were outlawed by an emergency order after the state's poison center received more than 125 calls in the last three months of 2010 involving exposure to the chemicals.
In Brown's case, he said he had tried every drug from heroin to crack and was so shaken by terrifying hallucinations that he wrote to one Mississippi paper urging people to stay away from the bath salts.
"I couldn't tell you why I did it," Brown said, pointing to his scars. "The psychological effects are still there."
While Brown survived, sheriff's authorities in one Mississippi county say they believe one woman overdosed on bath salts there. In southern Louisiana, the family of a 21-year-old man says he cut his throat and ended his life with a gunshot. Authorities are investigating whether a man charged with capital murder in the December death of a Tippah County, Miss., sheriff's deputy was under the influence of the bath salts.
The stimulants are not regulated by the Drug Enforcement Administration, but are facing federal scrutiny. Law officers say some of the substances are being shipped from Europe, but origins are still unclear.
Gary Boggs, an executive assistant at the DEA, said there is a lengthy process to restrict these types of designer chemicals, including reviewing the abuse data. But it's a process that can take years.
Mark Ryan, director of Louisiana's poison control center, said he thinks state bans on the chemicals can be effective. He said calls about the salts have dropped sharply since Louisiana banned their sale in January.
Ryan said cathinone, the parent substance of the drugs, comes from a plant grown in Africa and is regulated. He said that MDPV and mephedrone are made in a lab and that they are not regulated because they are not marketed for human consumption. The stimulants affect neurotransmitters in the brain, he said.
The drugs cause "intense cravings," he said. "They'll binge on it three or four days before they show up in an ER. Even though it's a horrible trip, they want to do it again and again."
Ryan said at least 25 states have received calls about exposure, including Nevada and California. He said Louisiana leads with the greatest number of cases at 165, or 48 percent of the U.S. total, followed by Florida with at least 38 calls to its poison center.
Rick Gellar, medical director for the California Poison Control System, said the first call about the substances came in Oct. 5, and a handful of calls have followed since. But he warned: "The only way this won't become a problem in California is if federal regulatory agencies get ahead of the curve. This is a brand-new thing."
In the Midwest, the Missouri Poison Center at Cardinal Glennon Children's Medical Center in St. Louis received at least 12 calls in the first two weeks of January about teenagers and young adults abusing such chemicals, said Julie Weber, the center's director. The center received eight calls about the powders all of last year.
Richard Sanders, a general practitioner working in Covington, La., said his son, Dickie, snorted some of the bath salts and endured three days of intermittent delirium. Dickie Sanders cut his throat but missed major arteries. As he continued to have visions, his physician father tried to calm him. But the elder Sanders said that as he slept, his son went into another room and shot himself.
"If you could see the contortions on his face. It just made him crazy," Sanders said. He added that the coroner's office confirmed that the chemicals were detected in his son's blood and urine.
Sanders warns that the bath salts are far more dangerous than some of their names imply.
"I think everybody is taking this extremely lightly. As much as we outlawed it in Louisiana, all these kids cross over to Mississippi and buy whatever they want," he said.
A small packet of the chemicals typically costs as little as $20.
In northern Mississippi's Itawamba County, Sheriff Chris Dickinson said his office has handled about 30 encounters with bath-salts users in the past two months alone. He said the problem grew last year in his rural area after a Mississippi law began restricting the sale of pseudoephedrine, a key ingredient in making methamphetamine.
Dickinson said most of the bath-salts users there have been meth addicts and can be dangerous when using them.
"We had a deputy injured a week ago. They were fighting with a guy who thought they were two devils. That's what makes this drug so dangerous," he said.
But Dickinson said the chemicals are legal, leaving him no choice but to slap users just with a charge of disorderly conduct, a misdemeanor.
Kentucky state lawmaker John Tilley said he's moving to block the drug's sale there, preparing a bill for consideration when his legislature convenes shortly. Angry that the powders can be bought legally, he said: "If my 12-year-old can go in a store and buy it, that concerns me."
ScienceDaily (Dec. 17, 2010) — A little-used medication can help treat alcoholism, an updated review of studies confirms. At any given time, about 5 percent of the population suffers from an addiction to alcohol, often with devastating consequences to work, family, friends and health. Twelve-step programs have been the mainstay for helping alcoholics to quit drinking, but a significant number of people who try these programs do not find them helpful or suffer relapses.
The Cochrane review finds that the medication naltrexone -- brand names are Depade and ReVia -- when combined with counseling or interventions like Alcoholics Anonymous, can help cut the risk of heavy drinking in patients who are dependent on alcohol.
Naltrexone works by blocking the pleasurable feelings, or "high," a person gets from drinking alcohol, thereby reducing motivation to drink. Naltrexone can be taken daily as a pill and is available as a long-acting injection.
The review was published by the Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
"Hundreds of drugs have been tried for relapse prevention [in alcoholism] and basically all others have failed," said Michael Soyka, M.D., senior author of the review. "From a clinical point of view, there are few pharmacologic options for the treatment of alcohol dependence, so it is important to study those options that look promising." Soyka and lead review author Suanne Roesner are associated with the psychiatric hospital at the University of Munich.
Alcohol dependence is different from alcohol abuse or misuse. The symptoms of alcohol dependence include craving for alcohol, an inability to control drinking, the presence of withdrawal symptoms if one tries to quit and tolerance -- the need to increase alcohol amounts to feel the same effect. People who only abuse alcohol and are not dependent on it have no trouble controlling their drinking, once they decide to do so.
Soyka and colleagues examined the results of 50 previously published high-quality studies on naltrexone and alcohol dependence. Overall, the studies enrolled nearly 7,800 patients diagnosed with alcohol dependence. Of these, about 4,200 patients took naltrexone or a similar drug called nalmefene. The rest of the patients took a placebo or had some other type of treatment. Treatment with naltrexone ranged from four weeks to a year, with most patients receiving about 12 weeks of treatment. Most patients also received counseling.
Researchers found that patients who received naltrexone were 17 percent less likely to return to heavy drinking than were patients who received a placebo treatment. "That would mean that naltrexone can be expected to prevent heavy drinking in one out of eight patients who would otherwise have returned to a heavy drinking pattern," Soyka said.
Naltrexone also increased the number of people who were able to stay abstinent by 4 percent.
While at first glance that might not seem like a miracle cure for alcoholism, Soyka said that the effectiveness of naltrexone is on par with medications used for other psychiatric conditions.
"Naltrexone is moderately effective in reducing alcohol intake. It's about as effective as antidepressants in depressive disorders," he said. "From a safety point of view, there are few safety concerns. Nausea is the most frequent side effect."
Carlton Erickson, Ph.D., director of the Addiction Science Research and Education Center at the University of Texas in Austin, says naltrexone can help a person with alcohol dependence move toward the goal of abstinence.
"Anytime you reduce the severity of drinking, the individual is more open to treatment for abstinence," he said. "It's almost like putting them through a series of steps if you can get them to cut down; once they start to cut down they are more likely to become abstinent with continued treatment and continued exposure to 12-step programs." Erickson is not associated with the review or any of its authors.
Despite its possible benefits in treating alcohol dependency, naltrexone is not widely used in the United States or elsewhere, Erickson said. Some addiction specialists fear that the widespread use of naltrexone or other medications will result in patients not receiving the counseling or psychological interventions they need.
There is also a lingering attitude that the treatment of alcohol dependency must rely solely on psychological or spiritual methods.
"People in 12-step programs typically don't believe in medications for the treatment of alcoholism," Erickson said. "Therefore they are unlikely to accept anyone into their 12-step meetings who is on a medication like naltrexone. Secondly, they would not want to accept it for themselves, unless a physician talked them into it as part of their treatment plan."
In addition, most large alcohol treatment centers, with the exception of Hazelden, do not advocate for the use of medications in the management of addiction, he said.
However, Erickson said that naltrexone is FDA-approved only as an adjunct to abstinence-based therapies, like Alcoholics Anonymous. "Naltrexone is not something you give to someone who says 'I want to stop drinking, give me a pill.' Naltrexone is only a helper to that process. The medication itself is not a magic bullet."
The review discloses that two authors received speaker/consultancy/advisory board honoraria from pharmaceutical companies.
In their study, published January 4, 2011, in the advanced online edition ofMolecular Therapy, the researchers say this novel strategy might be the first to offer cocaine addicts a fairly simple way to break and reverse their habit. The approach could also be useful in treating other addictions, such as to nicotine, heroin, and methamphetamine.
"Our very dramatic data shows that we can protect mice against the effects of cocaine, and we think this approach could be very promising in fighting addiction in humans," says the study's lead investigator, Ronald G. Crystal, chairman and professor of genetic medicine at Weill Cornell Medical College.
"The vaccine suppresses the stimulant effects of the drug," said Scripps Research Professor Kim Janda, a co-author of the paper and a pioneer in the field of developing vaccines against addictive drugs such as cocaine. "Unlike other types of treatment, a vaccine such as this one does not interfere with the neurological targets of the drug, but instead blocks cocaine from ever reaching the brain in the first place."
In the new study, the vaccine effect lasted for at least 13 weeks, the longest time point evaluated in such an approach. Since the vaccine likely will not require multiple expensive infusions, the researchers hope that it can move quickly into human trials.
Clinically, this sort of therapy could be given to people in treatment programs to aid in their recovery. And, like most other types of treatment, it will only be useful for those who want the help.
"This vaccine would be most applicable for addicts who are who are interested in getting off the drug," said Janda, the Eli R. Callaway Jr. Chair in Chemistry and a member of the Skaggs Institute for Chemical Biology at Scripps Research. "In essence we view such vaccines as 'immuno-helpers' for treating substance abuse, and, in the case at hand, it might prove to be extremely useful for crack addicts whose relapse rate is exceedingly high."
The Drug
According to the latest statistics available from National Institutes of Health (NIH)National Institute on Drug Abuse (NIDA) in 2008 5.3 million Americans age 12 and older had abused cocaine in any form and 1.1 million had abused crack at least once in the year prior to being surveyed.
Cocaine, derived from the leaf of the Erythroxylaceae coca plant, is a highly potent drug that, as a salt, is either snorted or dissolved in water and injected directly into the bloodstream. The salt is also often neutralized to make an insoluble "free-base" form that is smoked.
Once ingested in the bloodstream, the drug crosses the blood - brain barrier and accumulates rapidly in the brain. "The brain levels rise very rapidly once cocaine is taken into the system," said Janda.
Addiction is a chronic disorder proposed to be precipitated by a combination of genetic, biological/pharmacological and social factors.
Addiction is a compulsion to repeat a behaviour regardless of its consequences.
A person who is addicted is sometimes called an addict.
Addiction is often characterized by a craving for more of the drug or behavior, increased physiological tolerance to exposure, and withdrawal symptoms in the absence of the stimulus.
Many drugs and behaviours that provide either pleasure or relief from pain pose a risk of addiction or dependency.
For more information about the topic Addiction, read the full article at Wikipedia.org, or see the following related articles:
Substance abuse — Substance abuse refers to the overindulgence in and dependence on a stimulant, depressant, chemical substance, herb (plant) or fungus leading to ... > read more
Drug addiction — Drug addiction, or substance dependence is the compulsive use of psychoactive drugs, to the point where the user has no effective choice but to ... > read more
Narcotic — A narcotic is an addictive drug that reduces pain, induces sleep and may alter mood or behaviour. In US legal context, narcotic refers to opium, ... > read more
Detox — Detox, short for detoxification, in general is the removal of toxic substances from the body. It is one of the functions of the liver and kidneys, ... > read more
Washington (SmartAboutHealth) – According to a new study, children of alcoholics are more likely to face and suffer from obesity than kids who are not born into a family with a history of alcoholism.
Researchers analyzed data that came from two different surveys that involves alcoholism.
The surveys were conducted through the 1990s as well as through the 2000s and involved over 75,000 people in total.
Researchers found that those who had a family history of alcoholism were far more likely to be obese than those who did not.
The belief is that this is due to the fact that the addiction may be passed odwn in the family.
The only difference is that the new entrants into these families are becoming addicted to junk food more than they are addicted to alcohol.
As the years went by in the study, they found that the more recent adults with a family history of alcoholism were more likely to suffer from obesity than those from the early 1990s.
The family history of alcoholism and obesity are more directly linked now because the food that is available today has more calories and more fat than the food some years ago.
Still, the addictive nature between these foods and the brain is similar to the addiction that is seen from alcohol.
Texas Drug Rehabs are starting to offer a newer type of therapy. This new type of therapy is called Equine Therapy. It has been used as a alternative form to psychotherapy for many years. Some addiction treatment programs in Texas are implementing this newer thearpy into their programs.
This alternative approach is being used to help in the healing process. With many Texas Drug and Alcohol rehabs embracing this form of therapy, we are seeing many techniques and models of this type of therapy surface. Some programs use elements of different styles and models of care around the Equine Therapy. For more information regarding this type of therapy please visit this article below.
New research shows that attending Alcoholics Anonymous meetings may increase spirituality and help decrease frequency and intensity of alcohol use
Alcoholics Anonymous is a widely known 12-step program that can help individuals control their dependence on alcohol, and spirituality is a large part
A new study shows that spirituality does increase over time, which can lead to better alcohol outcomes and an improved rate of recovery
These results indicate that spirituality is an important factor in the multi-faceted recovery from an alcohol-use disorder
Addictions, whether it is to drugs or alcohol, are a very difficult hurdle for individuals to overcome. But, there are ways to help people with their recovery through 12-step programs like Alcoholics Anonymous (AA). Many of these organizations, including AA, highlight spirituality as a very important factor, but the data surrounding its effectiveness have often been contested.
However, new research shows that as attendance of AA meetings increase, so do the participants spiritual beliefs, especially in those individuals who had low spirituality at the beginning of the study.
The results will be published in the March 2011 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.
John F. Kelly, lead author of the study, Associate Professor in Psychiatry at Harvard Medical School and the Associate Director of the Center for Addiction Medicine at Massachusetts General Hospital, said that while spirituality is an important aspect of AA recovery, it is not the only way they can help individuals.
"I've heard it said that AA is too spiritual, and I've also heard it said that AA is not spiritual enough for some people. Although this is not the only way that AA helps individuals recover, I think these findings support the notion that AA works in part by enhancing spiritual practices," Kelly said.
The researchers assessed more than 1,500 adults throughout their recovery process, with data being gathered at three, six, nine, 12, and 15 months. The study utilized data on their attendance to AA meetings, their individual spirituality/religiosity practices and overall alcohol-use outcomes to determine if spirituality is indeed a mechanism of behavior change.
The results indicated that there was a robust association between an increase in attendance to AA meetings with increased spirituality and a decrease in the frequency and intensity of alcohol use over time. One of the most interesting aspects of the research was that the same amount of recovery was seen in both agnostics and atheists, which indicates that while spirituality is an important mechanism of behavioral change for AA, it is not the only method used.
"Many people will be surprised that alcoholic patients with little or no interest in spirituality attended AA and seemed to change even more than did those who had a pre-existing, strong sense of spirituality," said Keith Humphreys, a Career Research Scientist with the Veterans Health Administration and Professor of Psychiatry at Stanford University. "AA is thus much more broad in its appeal than is commonly recognized."
The researchers also noted that while spirituality is an important aspect of recovery, it is still not known how these beliefs work in complement or competition with other recovery methods, as there are multiple.
"We have also found that AA participation leads to recovery by helping members change their social network and by enhancing individuals' recovery coping skills, motivation for continued abstinence, and by reducing depression and increasing psychological well-being," said Kelly.
"Down the road it will be important to conduct more qualitative research as well as further quantitative replication of our findings in order to understand more about how exactly spiritual practices and beliefs influence coping and behavioral change in recovery from addiction"
Source: John F. Kelly, Ph.D. Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital Keith Humphreys, Ph.D. Stanford University Alcoholism: Clinical & Experimental Research
Alcoholics may stop one drink with new pill. What about the second drink? In Europe a new medication is being used to help the fight of alcoholism. For many years the search for a pharmacological treatment answer in the fight against alcoholism has been sought. The drug, nalmefene from H. Lundbeck A/S in Valby, Denmark, blocks brain signals that make activities such as sex and drinking feel good. Should trials succeed, the medicine may win clearance in Europe as early as 2012, becoming the first new alcoholism treatment approved there in more than 15 years.
Most of the current medications are geared to fighting relapse once a person stops using alcohol. The focus of the new drug promises an attack of the problem from a different angle. The individual continues to drink while using this medication. Currently the method of abstinent is required for most people to become free from alcohol.
This new method of treatment raises many questions on it's effectiveness to stop alcoholism. The addiction treatment communities are champions for new tools, medications, tecniques and approaches to the treatment of alcoholism. However, much concern exist when you hear of the magic pill cure to fight alcoholism. It does not take long for the addiction professionals and the treatment and recovery community to get cynical about the idea of giving a pill and continued drinking.
New ideas are always evaluated and researched in the addiction treatment industry. So while we watch this new approach to medication and alcoholics develop I hope more people will focus on the education of alcoholism.
By Scott Kelley LCDC
More information on article found at business week.
